Related references
Note: Only part of the references are listed.A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer
Peng Gu et al.
MOLECULAR CANCER (2019)
SNHG1 contributes to proliferation and invasion by regulating miR-382 in breast cancer
Shipeng Zheng et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Effects of LncRNA Lnc-LIF-AS on cell proliferation, migration and invasion in a human cervical cancer cell line
Weiguo Song et al.
CYTOKINE (2019)
Long non-coding RNA SNHG1 functions as a competitive endogenous RNA to regulate PDCD4 expression by sponging miR-195-5p in hepatocellular carcinoma
Dongli Huang et al.
GENE (2019)
Long non-coding RNA DILC suppresses bladder cancer cells progression
Qian-Yun Ma et al.
GENE (2019)
Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer
Lijian Chen et al.
MOLECULAR CANCER (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDH via sponging miR-145-5p
Qingchun Lu et al.
FASEB JOURNAL (2018)
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
Kaja Skjefstad et al.
SCIENTIFIC REPORTS (2018)
Lnc-SNHG1 may promote the progression of non-small cell lung cancer by acting as a sponge of miR-497
Zhanxia Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Lung Cancer Screening
Richard M. Hoffman et al.
MEDICAL CLINICS OF NORTH AMERICA (2017)
Upregulated lncRNA SNHG1 contributes to progression of nonsmall cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway
Yun Cui et al.
ONCOTARGET (2017)
Long non-coding RNA SNHG1 regulates zinc finger E-box binding homeobox 1 expression by interacting with TAp63 and promotes cell metastasis and invasion in Lung squamous cell carcinoma
Hong-Yan Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC
Wei Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Knockdown of FRAT1 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/β-catenin pathway in hepatocellular carcinoma cells
Wan-Hu Fan et al.
ONCOLOGY REPORTS (2016)
TMPRSS4 regulates levels of integrin a5 in NSCLC through miR-205 activity to promote metastasis
L. Larzabal et al.
BRITISH JOURNAL OF CANCER (2014)
Noncoding RNA small nucleolar RNA host gene 1 promote cell proliferation in nonsmall cell lung cancer
J. You et al.
INDIAN JOURNAL OF CANCER (2014)
Competing Endogenous RNA: The Key to Posttranscriptional Regulation
Rituparno Sen et al.
SCIENTIFIC WORLD JOURNAL (2014)
Roles for MicroRNAs in Conferring Robustness to Biological Processes
Margaret S. Ebert et al.
CELL (2012)
Low Levels of Cell-Free Circulating miR-361-3p and miR-625*as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors
Carina Roth et al.
PLOS ONE (2012)
Prognostic Significance of Serum miRNA-21 Expression in Human Non-Small Cell Lung Cancer
Zhao-Xia Wang et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer
Yong Zhang et al.
VIRCHOWS ARCHIV (2011)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Share Paper
